CD3D and cancer: Flow cytometry was performed to identify and collect the cancer cells marked by EPCAM, T cells marked by CD3D, CD8+ T cells marked by CD8A, and CD4+ T cells marked by CD4 in the GGN-ADC and SADC samples (Fig. 8a, b).